Lupus Clinical Trial
Official title:
A Randomized Multicenter Trial Comparing Leflunomide and Azathioprine as Remission-Maintaining Treatment for Proliferative Lupus Glomerulonephritis.
Leflunomide versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Proliferative glomerulonephritis is a common and severe manifestation of systemic lupus erythematosus (SLE) that usually requires intensive therapy with high doses of glucocorticosteroids and cytotoxic drugs, such as intravenous (IV) cyclophosphamide (CYC). The objective of this Trial is to compare leflunomide (LEF) and azathioprine (AZA), in terms of efficacy and toxicity, as remission-maintaining treatment of proliferative lupus glomerulonephritis, after a remission-inducing therapy with a short-course IV CYC regimen. The hypothesis of this trial is that LEF is non-inferior to AZA. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06013995 -
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
|
Phase 1 | |
| Recruiting |
NCT03952624 -
Patient-Centered Assessment of Symptoms and Outcomes
|
||
| Terminated |
NCT01389895 -
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
|
Phase 1 | |
| Completed |
NCT00710021 -
Vitamin D3 in Systemic Lupus Erythematosus
|
Phase 2 | |
| Completed |
NCT02265744 -
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
|
Phase 2 | |
| Recruiting |
NCT06445127 -
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
|
N/A | |
| Completed |
NCT00581763 -
Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
|
N/A | |
| Completed |
NCT00299819 -
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
| Completed |
NCT00054938 -
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
|
Phase 2 | |
| Terminated |
NCT03953690 -
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
|
||
| Recruiting |
NCT05715463 -
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
|
N/A | |
| Enrolling by invitation |
NCT05321108 -
Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus
|
N/A | |
| Completed |
NCT00482989 -
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus
|
Phase 1 | |
| Completed |
NCT00657189 -
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
|
Phase 2 | |
| Recruiting |
NCT04334031 -
Deployment o the Multidisciplinary Prospective Cohort Imminent
|
N/A | |
| Completed |
NCT03402087 -
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
|
Phase 1 | |
| Completed |
NCT02857452 -
Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
|
N/A | |
| Terminated |
NCT03186794 -
Aerobic Exercise in Women With Systemic Lupus Erythematosus
|
N/A | |
| Recruiting |
NCT05922722 -
Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
|
||
| Completed |
NCT03093402 -
JBT-101 in Systemic Lupus Erythematosus (SLE)
|
Phase 2 |